MLLT10 rearranged acute leukemia-finding order in ambiguity—a case series from a North Indian tertiary care center
Authors:
- 26 August 2026
- journal article
- letter
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 67 (11) , 2372-2375
Abstract
Dear EditorMLLT10 fusions, particularly with PICALM as fusion partner, hold prognostic or therapeutic significance as per European LeukemiaNet (ELN) and have been classified under ‘AML, along with ...Keywords
This publication has 11 references indexed in Scilit:
- Clonal Evolution and Lineage Switch from T‐Cell Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia in Therapy‐Resistant PICALM::MLLT10 LeukemiaeJHaem, 2026
- PICALM-MLLT10 fusion gene in hematological neoplasms: clinical features, current practices, and prognosesHematology, 2024
- PICALM::MLLT10 may indicate a new subgroup of acute leukemias with miscellaneous immunophenotype and poor initial treatment response but showing sensitivity to venetoclaxeJHaem, 2024
- Structural variants involving MLLT10 fusion are associated with adverse outcomes in pediatric acute myeloid leukemiaBlood Advances, 2024
- Genomic and global gene expression profiling in pediatric and young adult acute leukemia with PICALM::MLLT10 FusionLeukemia, 2024
- PHF6-altered T-ALL Harbor Epigenetic Repressive Switch at Bivalent Promoters and Respond to 5-Azacitidine and VenetoclaxClinical Cancer Research, 2023
- Treatment outcomes of childhood PICALM::MLLT10 acute leukaemiasBritish Journal of Haematology, 2023
- MLLT10 rearranged acute leukemia: Incidence, prognosis, and possible therapeutic strategiesGenes, Chromosomes and Cancer, 2020
- PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiationBlood Advances, 2018
- The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrestHaematologica, 2013